Recent research is reshaping the medical perspective on the use of fish oil supplements leading up to surgery. Traditional advice has been to discontinue fish oil before surgery to avoid bleeding complications. However, current analyses of randomized clinical trials involving over 120,000 patients suggest no significant increase in bleeding risk for those on omega-3 polyunsaturated fatty acids (PUFAs) compared to control groups.
A comprehensive review has highlighted that specific bleeding concerns, such as those related to haemorrhagic stroke or intracranial bleeding, are not significantly heightened by omega-3 PUFAs. Although a modest risk increase was observed in patients taking high-dose purified eicosapentaenoic acid (EPA), the absolute risk remains low. Background antiplatelet therapy does not appear to contribute notably to this risk, indicating that most patients may not need to cease fish oil supplementation pre-surgery.
These findings prompt a reconsideration of preoperative protocols regarding fish oil supplements. The evidence suggests that the potential bleeding risk may be overstated, offering patients and healthcare practitioners updated information for surgical planning. Such insights are critical for making informed, evidence-based choices in the context of pre-surgical care.
Recent insights transform the medical view on fish oil supplements before surgery. Past advice urged stopping fish oils to prevent bleeding. However, analysis of trials with over 120,000 patients shows no major bleeding risk increase for omega-3 PUFAs users. Comprehensive reviews reveal minimal bleeding concerns, like haemorrhagic stroke, remain unchanged with omega-3s. High-dose EPA shows a slight risk rise, yet absolute risk stays low. Antiplatelet therapy typically doesn't amplify risk, suggesting most patients might maintain fish oils pre-surgery. This prompts a reevaluation of surgical protocols, guiding informed decisions in pre-surgical care.
Read more...
Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, but new research suggests curcumin—a powerful compound in turmeric—may help prevent and slow its progression. A large-scale study found that individuals taking curcumin-based nutritional supplements (CBNS) had a significantly lower risk of developing AMD, experiencing vision loss, or needing anti-VEGF treatment. With its anti-inflammatory and neuroprotective properties, curcumin offers a promising natural approach to protecting aging eyes. Learn more about how curcumin supports eye health and how to incorporate it into your routine.
